Discovery of a novel Nav1.5 inhibitor reducing cardiac conduction via structure-based virtual screening and assays
{{output}}
Nav1.5 is the main sodium channel subtype in the heart, playing a crucial role in maintaining regular cardiac electrical activity. It is a well-established therapeutic target for class I antiarrhythmic drugs used to treat both inherited and acquired arrhythmia... ...
